Wall Street brokerages expect Envista Holdings Co. (NYSE:NVST) to report earnings per share of $0.40 for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Envista’s earnings, with estimates ranging from $0.35 to $0.45. Envista reported earnings per share of $0.52 in the same quarter last year, which would indicate a negative year over year growth rate of 23.1%. The business is expected to issue its next quarterly earnings report on Thursday, February 4th.
According to Zacks, analysts expect that Envista will report full-year earnings of $0.82 per share for the current year, with EPS estimates ranging from $0.75 to $0.87. For the next financial year, analysts anticipate that the company will report earnings of $1.48 per share, with EPS estimates ranging from $1.32 to $1.61. Zacks’ EPS calculations are an average based on a survey of research analysts that follow Envista.
Envista (NYSE:NVST) last issued its earnings results on Thursday, October 29th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.39. Envista had a negative net margin of 0.84% and a positive return on equity of 4.30%. The business had revenue of $640.50 million for the quarter, compared to analyst estimates of $509.18 million.
NYSE NVST opened at $35.84 on Thursday. The company has a current ratio of 2.09, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The stock’s 50 day moving average is $33.21 and its two-hundred day moving average is $29.48. The company has a market capitalization of $5.72 billion, a price-to-earnings ratio of -275.69 and a beta of 1.97. Envista has a 1-year low of $10.08 and a 1-year high of $36.50.
A number of large investors have recently modified their holdings of the business. Vanguard Group Inc. raised its stake in shares of Envista by 39.2% in the second quarter. Vanguard Group Inc. now owns 14,388,256 shares of the company’s stock worth $303,449,000 after acquiring an additional 4,055,356 shares during the last quarter. Nuveen Asset Management LLC lifted its holdings in Envista by 54.1% during the 2nd quarter. Nuveen Asset Management LLC now owns 4,824,421 shares of the company’s stock worth $101,747,000 after buying an additional 1,694,633 shares in the last quarter. Bank of America Corp DE boosted its position in Envista by 120.8% in the 2nd quarter. Bank of America Corp DE now owns 1,297,553 shares of the company’s stock valued at $27,365,000 after buying an additional 709,916 shares during the last quarter. Jacobs Levy Equity Management Inc. acquired a new stake in shares of Envista in the 2nd quarter valued at $5,499,000. Finally, BlackRock Inc. increased its stake in shares of Envista by 2.0% in the 3rd quarter. BlackRock Inc. now owns 11,551,850 shares of the company’s stock valued at $285,100,000 after buying an additional 230,870 shares during the period. 96.92% of the stock is currently owned by hedge funds and other institutional investors.
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures and markets dental products in the United States and internationally. The company operates in two segment, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare systems, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.